Effect of topical prostaglandin analog use on outcome following selective laser trabeculoplasty

Journal of Ocular Pharmacology and Therapeutics

Volumn 23, Issue 5, 2007, Pages 503-512

  Scherer, Warren J ^a  

^a Montgomery Eye Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIMATOPROST; BRIMONIDINE; CARBONATE DEHYDRATASE INHIBITOR; LATANOPROST; PROSTAGLANDIN DERIVATIVE; TRAVOPROST;

AGED; ANALYTIC METHOD; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; INTRAOCULAR PRESSURE; LASER SURGERY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OPEN ANGLE GLAUCOMA; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDY; TRABECULOPLASTY;

ADMINISTRATION, TOPICAL; AGED; AMIDES; ANTIHYPERTENSIVE AGENTS; CLOPROSTENOL; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; LASER THERAPY; LIPIDS; MALE; PERIOPERATIVE CARE; POSTOPERATIVE PERIOD; PROSTAGLANDINS F, SYNTHETIC; RETREATMENT; RETROSPECTIVE STUDIES; TRABECULECTOMY; TREATMENT OUTCOME;

EID: 36749018097     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2007.0027     Document Type: Article

References (59)

1. Latina, M.A., Sibayan, S.A., Shin, D.H., et al. Q-switched 532-nm Nd:YAG laser trabeculoplasty (selective laser trabeculoplasty): A multicenter, pilot, clinical study. Ophthalmology 105(11):2082-2088, 1998.
2. Kramer, T.R., and Noecker, R.J. Comparison of the morphologic changes after selective laser trabeculoplasty and argon laser trabeculoplasty in human eye bank eyes. Ophthalmology 108(4):773-779, 2001.
3. Juzych, M.S., Chopra, V., Banitt, M.R., et al. Comparison of long-term outcomes of selective laser trabeculoplasty versus argon laser trabeculoplasty in open-angle glaucoma. Ophthalmology 2004. 111(10):1853-1859, 2004.
4. Martinez-de-la-Casa, J.M., Garcia-Feijoo, J., Castillo, A., et al. Selective versus argon laser trabeculoplasty: Hypotensive efficacy, anterior chamber inflammation, and postoperative pain. Eye 18(5):498-502, 2004.
5. Watson, P.G., for the Latanoprost Study Group. Latanoprost: Two years' experience of its use in the United Kingdom. Ophthalmology 105:82-107, 1998.
6. Gabelt, B.T., and Kaufman, P.L. Prostaglandin F-2α increases uveoscleral outflow in the cyanomolgus monkey. Exp. Eye Res. 49:389-402, 1989.
7. Toris, C.B., Camras, C.B., and Yablonski, M.E. Effects of PhXA41, a new prostaglandin F2-α analog, on aqueous humor dynamics in human eyes. Ophthalmology 100:1297-1304, 1993.
8. Thieme, H., Schimmat, C., Munzer, G., et al. Endothelin antagonism: Effects of FP receptor agonists prostaglandin F2alpha and fluprostenol on trabecular meshwork contractility. Invest. Ophthalmol. Vis. Sci. 47(3):938-945, 2006.
9. Weinreb, R.N., Kashiwagi, K., Kashiwagi, F., et al. Prostaglandins increase matrix metalloproteinase release from human ciliary muscle cells. Invest. Ophthalmol. Vis. Sci. 38(13):2772-2780, 1997.
10. Woessner, J.F. The family of matrix metalloproteinases. Ann. N.Y. Acad. Sci. 732:11-21, 1994.
11. Pepper, M.S., and Montesano, R. Proteolytic balance and capillary morphogenesis. Cell. Diff. Dev. 32:319-327, 1990.
12. Mignati, P., and Rifkin, D.B. Plasminogen activators and matrix metalloproteinases in angiogenesis. Enz. Prot. 49:117-137, 1996.
13. Madlener, M., Parks, W.C., and Werner, S. Matrix metalloproteinases (MMPs) and their physiological inhibitors (TIMPs) are differentially expressed during excisional skin wound repair. Exp. Cell. Res. 242:201-210, 1998.
14. Moses, M.A., Marikovsky, M., Harper, J.W., et al. Temporal study of the activity of matrix metalloproteinases and their endogenous inhibitors during wound healing. J. Cell. Biochem. 60:379-386, 1996.
15. Cawston, T. Matrix metalloproteinase inhibitors and the prevention of connective tissue breakdown. Pharmacol. Ther. 70:163-182, 1996.
16. Gaton, D.D., Sagara, T., Lindsey, J.D., et al. Increased matrix metalloproteinases 1, 2, and 3 in the monkey uveoscleral outflow pathway after topical prostaglandin F-2α-isopropyl ester treatment. Arch. Ophthalmol. 119:1165-1170, 2001.
17. Richter, M., Krauss, A.H., Woodward, D.F., et al. Morphological changes in the anterior eye segment after long-term treatment with different receptor selective prostaglandin agonists and a prostamide. Invest. Ophthalmol. Vis. Sci. 44(10):4419-4426, 2003.
18. Kashiwagi, K., Jin, M., Suzuki, M., et al. Isopropyl unoprostone increases the activities of matrix metalloproteinases in cultured monkey ciliary muscle cells. J. Glauc. 10(4):271-276, 2001.
19. Ocklind, A. Effect of latanoprost on the extracellular matrix of the ciliary muscle: A study on cultured cells and tissue sections. Exp. Eye Res. 67(2):179-191, 1998.
20. el-Shabrawi, Y., Eckhardt, M., Berghold, A., et al. Synthesis pattern of matrix metalloproteinases (MMPs) and inhibitors (TIMPs) in human explant organ cultures after treatment with latanoprost and dexamethasone. Eye 14(3A):375-383, 2000.
21. Weinreb, R.N., and Lindsey, J.D. Metalloproteinase gene transcription in human ciliary muscle cells with latanoprost. Invest. Ophthalmol. Vis. Sci. 43(3):716-722, 2002.
22. Kamphuis, W., Schneemann, A., van Beek, L.M., et al. Prostanoid receptor gene expression profile in human trabecular meshwork: A quantitative real-time PCR approach. Invest. Ophthalmol. Vis. Sci. 42(13):3209-3215, 2001.
23. Schlotzer-Schrehardt, U., Zenkel, M., and Nusing, R.M. Expression and localization of FP- and EP prostanoid receptor subtypes in human ocular tissues. Invest. Ophthalmol. Vis. Sci. 43(5):1475-1487, 2002.
24. Anthony, T.L., Pierce, K.L., Stamer, W.D., et al. Prostaglandin F2 alpha receptors in the human trabecular meshwork. Invest. Ophthalmol. Vis. Sci. 39(2):315-321, 1998.
25. Sharif, N.A., Kelly, C.R., and, Crider, J.Y. Human trabecular meshwork cell responses induced by bimatoprost, travoprost, unoprostone, and other FP prostaglandin receptor agonist analogues. Invest. Ophthalmol. Vis. Sci. 44(2):715-721, 2003.
26. Zhao, X., Pearson, K.E., Stephan, D.A., et al. Effects of prostaglandin analogues on human ciliary muscle and trabecular meshwork cells. Invest. Ophthalmol. Vis. Sci. 44(5):1945-1952, 2003.
27. Pang, I.H., Hellberg, P.E., Fleenor, D.L., et al. Expression of matrix metalloproteinases and their inhibitors in human trabecular meshwork cells. Invest. Ophthalmol. Vis. Sci. 44(8):3485-3493, 2003.
28. Gabelt, B.T., and Kaufman, P.L. The effect of prostaglandin F2 alpha on trabecular outflow facility in cynomolgus monkeys. Exp. Eye Res. 51(1):87-91, 1990.
29. Traverso, C.E., Spaeth, G.L., Starita, R.J., et al. Factors affecting the results of argon laser trabeculoplasty in open-angle glaucoma. Ophthalmic Surg. 17(9):555-559, 1986.
30. Brooks, A.M., and Gillies, W.E. Do any factors predict a favourable response to laser trabeculoplasty? Aust. J. Ophthalmol. 12(2):149-153, 1984.
31. Chen, E., Golchin, S., and Blomdahl, S. A comparison between 90-degree and 180-degree selective laser trabeculoplasty. J. Glauc. 13:62-65, 2004.
32. Camras, C.B., Alm, A., Watson, P., et al. Latanoprost, a prostaglandin analog, for glaucoma therapy: Efficacy and safety after 1 year of treatment in 198 patients. The Latanoprost Study Groups. Ophthalmology 103(11):1916-1924, 1996.
33. Nakamura, Y., Nakamura, Y., Morine-Shinjo, S., et al. Assessment of chamber angle pigmentation during longterm latanoprost treatment for open angle glaucoma. Acta. Ophthalmol. (Scand). 82(2):158-160, 2004.
34. Lepple-Wienhues, A., Stahl, F., and Wiederholt, M. Differential smooth muscle-like contractile properties of trabecular meshwork and ciliary muscle. Exp. Eye Res. 53(1):33-38, 1991.
35. Lepple-Wienhues, A., Stahl, F., Wunderling, D., et al. Effects of endothelin and calcium channel blockers on membrane voltage and intracellular calcium in cultured bovine trabecular meshwork cells. Ger. J. Ophthalmol. 1(3-4):159-163, 1992.
36. Hollo, G., and Lakatos, P. Increase of endothelin-1 concentration in aqueous humour induced by argon laser trabeculoplasty in the rabbit: A preliminary study. Acta. Ophthalmol. (Scand). 76(3):289-293, 1998.
37. Hollo, G., Lakatos, P., and Vargha, P. Immediate increase in aqueous humour endothelin 1 concentration and intraocular pressure after argon laser trabeculoplasty in the rabbit. Ophthalmologica 214(4):292-295, 2000.
38. Hollo, G., Kothy, P., Lakatos, P., et al. Endothelin-A receptor antagonist BQ-485 protects against intraocular pressure spike induced by laser trabeculoplasty in the rabbit. Ophthalmologica 216(6):459-462, 2002.
39. Yadav, V.K., Lakshmi, G., and Medhamurthy, R. Prostaglandin F-2-alpha-mediated activation of apoptotic signaling cascades in the corpus luteum during apoptosis: Involvement of caspase-activated DNase. J. Biol. Chem. 280(11):10357-10367, 2005.
40. Hamard, P., Blondin, C., Debbasch, C., et al. In vitro effects of preserved and unpreserved antiglaucoma drugs on apoptotic marker expression by human trabecular cells. Graefe's Arch. Clin. Exp. Ophthalmol. 241(12):1037-1043, 2003.
41. Vindrieux, D., Reveiller, M., Florin, A., et al. TNF-alpha-related apoptosis-inducing ligand decoy receptor DcR2 is targeted by androgen action in the rat ventral prostate. J. Cell. Physiol. 206(3):709-717, 2006.
42. Keane, M.M., Ettenberg, S.A., Nau, M.M., et al. Chemotherapy augments TRAIL-induced apoptosis in breast cell lines. Cancer Res. 59:734-741, 1999.
43. Huerta-Yepez, S., Vega, M., Jazirehi, A., et al. Nitric oxide sensitizes prostate carcinoma cell lines to TRAIL-mediated apoptosis via inactivation of NF-KB and inhibition of Bcl-xL expression. Oncogene 23:4993-5003, 2004.
44. Arnould, T., Thibaut-Vercruyssen, R., Bouaziz, N., et al. PGF(2alpha), a prostanoid released by endothelial cells activated by hypoxia, is a chemoattractant candidate for neutrophil recruitment. Am. J. Pathol. 159(1):345-357, 2001.
45. Parshley, D.E., Bradley, J.M., Samples, J.R., et al. Early changes in matrix metalloproteinases and inhibitors after in vitro laser treatment to the trabecular meshwork. Curr. Eye Res. 14(7):537-544, 1995.
46. Parshley, D.E., Bradley, J.M., Fisk, A., et al. Laser trabeculoplasty induces stromelysin expression by trabecular juxtacanalicular cells. Invest. Ophthalmol. Vis. Sci. 37(5):795-804, 1996.
47. Bradley, J.M., Anderssohn, A.M., Colvis, C.M., et al. Mediation of laser trabeculoplasty-induced matrix metalloproteinase expression by IL-1 beta and TNF alpha. Invest. Ophthalmol. Vis. Sci. 41(2):422-430, 2000.
48. Wirtz, M.K., Xu, H., Rust, K., et al. Insulin-like growth factor binding protein-5 expression by human trabecular meshwork. Invest. Ophthalmol. Vis. Sci. 39(1):45-53, 1998.
49. Shapiro, S.D. Elastolytic metalloproteinases produced by human mononuclear phagocytes: Potential roles in destructive lung disease. Am. J. Respir. Crit. Care Med. 150(6 Pt. 2):S160-S164, 1994.
50. Okamoto, Y., Satomura, K., Ohsuzu, F., et al. Expression of matrix metalloproteinase 3 in experimental atherosclerotic plaques. J. Atheroscler. Thromb. 8(2):50-54, 2001.
51. Luan, Z., Chase, A.J., and Newby, A.C. Statins inhibit secretion of metalloproteinases-1, -2, -3, and -9 from vascular smooth muscle cells and macrophages. Arterioscler. Thromb. Vasc. Biol. 23(5):769-775, 2003.
52. Melamed, S., Pei, J., and Epstein, D.L. Short-term effect of argon laser trabeculoplasty in monkeys. Arch. Ophthalmol. 103(10):1546-1552, 1985.
53. Alexander, R.A., Grierson, I., and Church, W.H. The effect of argon laser trabeculoplasty upon the normal human trabecular meshwork. Graefe's Arch. Clin. Exp. Ophthalmol. 227(1):72-77, 1989.
54. Damji, K.F., Shah, K.C., Rock, W.J., et al. Selective laser trabeculoplasty versus argon laser trabeculoplasty: A prospective randomised clinical trial. Br. J. Ophthalmol. 83(6):718-722, 1999.
55. Cvenkel, B. One-year follow-up of selective laser trabeculoplasty in open-angle glaucoma. Ophthalmologica 218(1):20-25, 2004.
56. Melamed, S., Ben Simon, G.J., and Levkovitch-Verbin, H. Selective laser trabeculoplasty as primary treatment for open-angle glaucoma: A prospective, nonrandomized pilot study. Arch. Ophthalmol. 121(7):957-960, 2003.
57. Song, J., Lee, P.P., Epstein, D.L., et al. High failure rate associated with 180 degrees selective laser trabeculoplasty. J. Glauc. 14(5):400-408, 2005.
58. Lai, J.S., Chua, J.K., Tham, C.C., et al. Five-year follow up of selective laser trabeculoplasty in Chinese eyes. Clin. Exp. Ophthalmol. 32(4):368-372, 2004.
59. Johnson, P.B., Katz, L.J., and Rhee, D.J. Selective laser trabeculoplasty: Predictive value of early intraocular pressure measurements for success at 3 months. Br. J. Ophthalmol. 90(6):741-743, 2006.